John Galligan, MD
Foot and Ankle Surgery · Lawrence, KSNPI 1194773689
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (41.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Arthrex at 43.5% of the total. Reporting peaked in 2022 at $5,616 and has fallen 91.8% since, to $463 in 2025.
Across 115 payments — averaging $107.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- Zimmer Biomet$2K
- Titan Surgical Group, LLC$1K
- Stryker$1K
- Conetic Solutions, Inc.$750
- Musculoskeletal Transplant Foundation Inc.$245
- plus $837 from 15 others
What the payments were for
- Travel & lodging$4,26934%
- Food & beverage$3,00024%
- Education$5,11241%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 38 | $5,382 |
| Zimmer Biomet | 23 | $2,381 |
| Titan Surgical Group, LLC | 2 | $1,460 |
| Stryker | 13 | $1,325 |
| Conetic Solutions, Inc. | 7 | $750 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $245 |
| RSW Medical Company, Inc. | 2 | $233 |
| Medtronic | 1 | $147 |
| Integra Lifesciences Corporation | 3 | $81 |
| Orthofix Medical, Inc. | 8 | $66 |
| Johnson & Johnson | 3 | $59 |
| Treace Medical Concepts, Inc. | 2 | $58 |
| Pacira Pharmaceuticals Incorporated | 1 | $30 |
| Amgen | 2 | $28 |
| Sanara Medtech Inc. | 2 | $26 |
| Vertex | 1 | $24 |
| SPR Therapeutics, Inc | 1 | $24 |
| Bioventus LLC | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| AbbVie | 1 | $13 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,381 in reported general payments places this provider in the 85th percentile of 40 foot and ankle surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $213 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $137 |
| Cephalexin | 16 | $92 |
| Ondansetron OdtOndansetron | 15 | $76 |
| Oxycodone Hcl | 11 | $74 |
| Gabapentin | 12 | $65 |
| Meloxicam | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Lawrence
- Patrick McGregorLawrence$24K
- Steven OstiguyLawrence$7K
- Kerwin DunhamLawrence$1K
- Greg HortonKansas City$1.1M
- Melissa JournotLeawood$26K
- Zhipeng YangKansas City$25K
- Andrea DrielingHutchinson$16K
- Lucas CosensSalina$10K
- Sarah RussellLeawood$9K
- Scott GordonPratt$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.